Scientist at Work | Andrew Witty: Ally for the Poor in an Unlikely Corner

Monday, February 8, 2010 - 18:00 in Mathematics & Economics

Through his work in poor countries, Andrew Witty, chief executive of GlaxoSmithKline, has positioned his company as the leader among drug makers in advancing world health issues.

Read the whole article on NY Times Science

More from NY Times Science

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net